Physician profile
Vikas Sethi
NPI 1780823559
$1,360.48
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $993 · 2022: $296 · 2023: $20.10 · 2024: $51.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $72.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $72.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $166.80 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $163.72 | 2021-2022 | |
| Novo Nordisk INC | $160.34 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $152.22 | 2021-2024 | Airsupra |
| Merck Sharp & Dohme LLC | $89.60 | 2021 | |
| Amgen INC. | $82.13 | 2021-2022 | |
| Currax Pharmaceuticals LLC | $78.23 | 2021-2022 | |
| Lilly USA, LLC | $71.07 | 2021-2022 | |
| Sunovion Pharmaceuticals INC. | $64.01 | 2021 | |
| Amarin Pharma, INC. | $50.50 | 2021-2022 | |
| Pfizer INC. | $43.71 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.53 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $38.43 | 2021 | |
| Abbott Laboratories | $26.54 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.97 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18.86 | 2021 | |
| Novartis Pharmaceuticals Corporation | $18.11 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $17.16 | 2022 | |
| Sanofi Pasteur INC. | $16.03 | 2021 | |
| Eisai INC. | $15.39 | 2021 | |
| Neurocrine Biosciences, INC. | $13.91 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $12.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikas Sethi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.